Chris O’Donnell

Company: Novartis Institutes of Biomedical Research

Job title: Global Head CVM

Seminars:

Opportunities & Challenges for Genomics to Enhance Biomarker- Guided Treatment Strategies in Prevention & Treatment of Cardiometabolic Disease 11:00 am

Determining ways to identify patients who would benefit from genetically oriented approaches such as siRNA, ASO and longer-term genome editing How do we ensure we’re treating patients early enough to improve their course of life? Ideal screening method: cascade, paediatric or population?Read more

day: Conference Day 1